Starts:  Dec 5, 2020 9:00 AM (ET)
Ends:  Dec 7, 2020 5:00 PM (ET)
Associated with  CCF General Community

Inflammatory Bowel Disease Dinner Symposium - December 5; 6-9.30 p.m. On the agenda: An Era of Choice in IBD: Which Drug First?; Health Maintenance & Preventative Care in Your IBD Patient; Transitioning Pediatric IBD Patients to Adult Care: It’s a Marathon, Not a Sprint! Bring difficult cases for discussion too.

On the agenda December 6-7:

  • Liver Transplantation for Alcoholic Hepatitis: The 6 Month Rule
  • Autoimmune Liver Disease
  • Update in Viral Hepatitis
  • Management in the Treatment of Obesity-Related Liver Disease
  • Hereditary Colon Cancer & Impact Upon Practice
  • Approach to the Patient with Reflux Symptoms & Normal EGD
  • EoE & PPI-Responsive Esophageal Eosinophilia
  • Cirrhosis: Clinical Challenges
  • Barrett’s Esophagus & Early Esophageal Cancer
  • IBD: Challenging Cases
  • Approach to Biliary Obstruction
  • Fatty Liver Disease
  • Gluten-Free Diet: Medical/Nutritional Considerations
  • Measuring Colonoscopy Quality
  • When to Refer to a Pediatric GI Doc
  • Manifestations of IBD: The Gut & Beyond
  • Screening & Management of Dysplasia in IBD
  • Therapeutic Drug Monitoring in IBD
  • Personalizing Post-Operative Care in IBD
  • Capsule Endoscopy
  • Fecal Microbial Transplant
  • Ordering & Interpreting Diagnostic Studies in Motility Disorders
  • The New Interstitium: How We Found It, Potential Importance
  • ESD: Update on Indications & Techniques
  • Endoscopic Interventions for Weight Loss
  • Pancreatic Disorders
  • Serrated Polyps/Serrated Polyposis Syndrome
  • Celiac Disease: Non-Dietary Therapies
  • Controversies in GI: Microbiome Testing
20 AMA PRA Category 1 Credits™ - maximum